• Indications
    • Superficial T1 cancer, limited to the submucosa
    • No radiographic evidence of metastatic disease to the regional nodes
    • Tumor <3 cm in diameter
    • Well-differentiated histology, no lymphovascular or perineural invasion
    • Mobile, non-fixed
    • Margin clear (>3 mm)
    • Involving <30 percent of the bowel lumen circumference
    • Patient is able to comply with frequent postoperative surveillance
  • If has a transanal excision and then adverse histology → proceed to trans-abdominal excision
    • If adverse features on histo, completion surgery has similar cancer-specific survival to upfront major rectal resection.
  • Options
    • TEMS (Transanal endoscopic microsurgery)
    • TAMIS (Transanal Minimally Invasive Surgery)
    • ESD
    • Ta-TME
      • Approached through rectotomy from below with an airseal system, followed by purse-string closure of the rectum.
FeatureTEMTAMIS
PlatformRigid rectoscope (specialized TEM scope)Uses standard laparoscopic instruments and a transanal access port (e.g., GelPOINT)
CostHigh (dedicated equipment required)Lower (reuses existing laparoscopic tools)
Learning CurveSteep (unique instrumentation and optics)Shorter (familiar laparoscopic setup)
Instrument MobilityLimited (due to rigid scope)Greater (laparoscopic instruments allow more maneuverability)
VisualisationHigh-definition 3D magnified opticsDepends on laparoscope; typically 2D, but improving
AccessLimited reach (mid to upper rectum best)Slightly more flexible, especially for distal lesions
Setup TimeLonger (due to scope and platform)Quicker (standard ports and instruments)
Use in PracticeLess common nowIncreasingly popular due to versatility and lower cost

TEMS

TAMIS